Octaplaslg (Human Plasma Protein)

Human Plasma Protein, the active ingredient in Octaplaslg, is a plasma-derived protein presented as a liquid for intravenous use. It supports hemostasis in patients with bleeding disorders or undergoing major surgery. GNH USA supplies Octaplaslg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Octaplaslg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Octaplaslg is used in the management of hemostatic disorders and surgical bleeding. It helps: - Massive transfusion protocols: restores coagulation factors and reduces bleeding risk. - Liver transplantation: provides balanced plasma proteins for coagulation support. - Cardiac surgery with cardiopulmonary bypass: maintains hemostasis during and after the procedure. - Severe trauma: supplies clotting factors when rapid hemostasis is required. - Congenital coagulation factor deficiencies (e.g., factor V deficiency): supplements missing plasma proteins.

Octaplaslg may elicit a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Fever - Chills - Headache - Nausea - Mild hypotension - Transfusion‑related urticurial (sic

Serious or Rare Side Effects: - Anaphylactic shock - Acute hemolytic transfusion reaction - Transfusion‑related acute lung injury (TRALI) - Severe allergic disease "); -  """""  """.

Octaplaslg    g   t   d  d  ewline

   g """  ewline \